Gatifloxacin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Gatifloxacin. Educational only — not medical advice.
Labeled uses
ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram-Positive Bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group* Streptococcus oralis * Streptococcus pneumoniae Aerobic Gram-Negative Bacteria: Haemophilus influenzae * Efficacy for this organism was studied in fewer than 10 infections.
Source: FDA labeling via NIH DailyMed (set 218fba79…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.